BRIANA MAIERLE: Open Payments
NPI 1801655071 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,384 in 44 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $663 · 2025 $1,384
Food & beverage: $1,384
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $224 |
| GENZYME CORPORATION | 3 | $188 |
| Amgen Inc. | 3 | $186 |
| Janssen Biotech, Inc. | 7 | $170 |
| ABBVIE INC. | 6 | $111 |
| Madrigal Pharmaceuticals | 3 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| Ferring Pharmaceuticals Inc. | 3 | $65 |
| Novo Nordisk Inc | 2 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $55 |
Products named: DUPIXENT, IBSRELA, UPLIZNA, TREMFYA, REZDIFFRA, REBYOTA, Wegovy, LINZESS.
Industry payments across FL — which companies pay providers there.
